Form 4/A for ASTH Astrana Health, Inc.
Accepted 2023-10-17 00:00:00 ET · period of report 2023-05-16 · accession 0001104659-23-109616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2023-10-17 | 2023-05-16 | ASTH | Basho Chandan | See Remarks | A - Grant | $0.00 | +130.7K | 96.3K | New | $0 |
| A | 2023-10-17 | 2023-05-16 | ASTH | Basho Chandan | See Remarks | D - Sale to Iss | $0.00 | -48.1K | 26.4K | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | A | A | 9,121 | $0.00 | 35,480 | D | — | — | (F5) These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023. (F2) Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 16, 2024. |
| 2 | Common | Common Stock | 2023-05-16 | A | A | 60,803 | $0.00 | 157,091 | D | — | — | (F4) Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest upon achievement of certain pre-established performance goals. (F5) These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023. (F6) Includes 152,372 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals. |
| 3 | Common | Common Stock | 2023-05-16 | D | D | 48,086 | $0.00 | 26,359 | D | — | — | (F1) Represents cancellation of previously-granted performance-based restricted stock award. The original Form 4 filed on May 25, 2023 inadvertently omitted this cancellation. Total holdings in column 5 have been adjusted accordingly, including for previously-reported tax withholdings. |
| 4 | Common | Common Stock | 2023-05-16 | A | A | 60,808 | $0.00 | 96,288 | D | — | — | (F3) Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in four equal (as nearly as possible) annual installments, beginning on May 16, 2024. (F5) These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023. |